FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Piramal Critical Care Gablofen Recall

Gablofen (baclofen injection), 50 mcg/mL, Single Use Syringe, Rx only, packaged in a bo…

Piramal Critical Care, Inc. · Bethlehem, PA

Risk level
Class II
Reported by FDA
Aug 7, 2019
Recall ID
D-1742-2019
Check your lot numberHow we source this data

Summary

Piramal Critical Care recalled Gablofen starting Jul 8, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1742-2019 on Aug 7, 2019. Reason: Failed Impurities/Degradation Specification -This recall is being initiated as a precaution due to the presence of an unknown impurity observed during shelf life of the product. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specification -This recall is being initiated as a precaution due to the presence of an unknown impurity observed during shelf life of the product.

Product description

Gablofen (baclofen injection), 50 mcg/mL, Single Use Syringe, Rx only, packaged in a box containing one 1 mL syringe, Distributed by: Primal Critical Care, Inc., 3950 Schelden Circle Bethlehem, PA, 18017, NDC 66794-151-01

Lot numbers, UPCs & expiration codes

Lot #: 2155-111, 2155-111A, Exp 6/20

Where it was sold

USA Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1742-2019
Classification
Class II
Status
Terminated
Recall initiated
Jul 8, 2019
FDA report date
Aug 7, 2019
Quantity
Lot 2155-111 (1,418 boxes) and Lot 2155-111A (5,640 boxes)
Recall type
Voluntary: Firm initiated
Recalling firm
Piramal Critical Care, Inc.

Original FDA data

Every field from FDA enforcement report D-1742-2019, exactly as published.

Show all FDA fields
City
Bethlehem
State
PA
Status
Terminated
Country
United States
Event ID
83280
Address
3950 Schelden Cir
Code information
Lot #: 2155-111, 2155-111A, Exp 6/20
Postal code
18017-8936
Report date
Aug 7, 2019
Product type
Drugs
Recall number
D-1742-2019
Classification
Class II
Recalling firm
Piramal Critical Care, Inc.
Product quantity
Lot 2155-111 (1,418 boxes) and Lot 2155-111A (5,640 boxes)
Termination date
Mar 9, 2021
Reason for recall
Failed Impurities/Degradation Specification -This recall is being initiated as a precaution due to the presence of an unknown impurity observed during shelf life of the product.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Gablofen (baclofen injection), 50 mcg/mL, Single Use Syringe, Rx only, packaged in a box containing one 1 mL syringe, Distributed by: Primal Critical Care, Inc., 3950 Schelden Circle Bethlehem, PA, 18017, NDC 66794-151-01
Distribution pattern
USA Nationwide
Recall initiation date
Jul 8, 2019
Initial firm notification
Letter
Center classification date
Aug 13, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1742-2019, published Aug 7, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls